Page 279 - Read Online

Chen MAGL in neurodegenerative diseases

REFERENCES neurodegenerative diseases. Rev Neurosci 2016;27:93-100.
10. Djordjevic J, Sabbir MG, Albensi BC. Traumatic brain injury as a
1. Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of an risk factor for Alzheimer’s disease: is inflammatory signaling a key
active constituent of hashish. J Am Chem Soc 1964;86:1646-7. player? Curr Alzheimer Res 2016;13:730-8.
2. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, 11. Zhang J, Hu M, Teng Z, Tang YP, Chen C. Synaptic and cognitive
Watanabe M. Endocannabinoid-mediated control of synaptic improvements by inhibition of 2-AG metabolism are through
transmission. Physiol Rev 2009;89:309-80. upregulation of microRNA-188-3p in a mouse model of Alzheimer’s
disease. J Neurosci 2014;34:14919-33.
3. Castillo PE, Younts TJ, Chávez AE, Hashimotodani Y. Endocannabinoid 12. Chen R, Zhang J, Wu Y, Wang D, Feng G, Tang YP, Teng Z, Chen
signaling and synaptic function. Neuron 2012;76:70-81. C. Monoacylglycerol lipase is a therapeutic target for Alzheimer’s
4. Xu JY, Chen C. Endocannabinoids in synaptic plasticity and disease. Cell Rep 2012;2:1329-39.
neuroprotection. Neuroscientist 2015;21:152-68. 13. Nomura DK, Morrison BE, Blankman JL, Long JZ, Kinsey SG,
5. Zhang J, Chen C. Endocannabinoid 2-arachidonoylglycerol protects Marcondes MC, Ward AM, Hahn YK, Lichtman AH, Conti B, Cravatt
neurons by limiting COX-2 elevation. J Biol Chem 2008;283:22601-11. BF. Endocannabinoid hydrolysis generates brain prostaglandins that
6. Blankman JL, Simon GM, Cravatt BF. A comprehensive profile of brain promote neuroinflammation. Science 2011;334:809-13.
enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. 14. Piro JR, Benjamin DI, Duerr JM, Pi Y, Gonzales C, Wood
Chem Biol 2007;14:1347-56. KM, Schwartz JW, Nomura DK, Samad TA. A dysregulated
7. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, endocannabinoid-eicosanoid network supports pathogenesis in a
Mechoulam R, Shohami E. An endogenous cannabinoid (2-AG) is mouse model of Alzheimer’s disease. Cell Rep 2012;1:617-23.
neuroprotective after brain injury. Nature 2001;413:527-31. 15. O’Sullivan SE. Cannabinoids go nuclear: evidence for activation
8. Zhang J, Teng Z, Song Y, Hu M, Chen C. Inhibition of of peroxisome proliferator-activated receptors. Br J Pharmacol
monoacylglycerol lipase prevents chronic traumatic encephalopathy- 2007;152:576-82.
like neuropathology in a mouse model of repetitive mild closed head 16. Du H, Chen X, Zhang J, Chen C. Inhibition of COX-2 expression by
injury. J Cereb Blood Flow Metab 2015;35:443-53. endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. Br
9. Gupta R, Sen N. Traumatic brain injury: a risk factor for J Pharmacol 2011;163:1533-49.

270 Neuroimmunology and Neuroinflammation ¦ Volume 3 ¦ December 15, 2016